Eli Lilly, J&J, Novartis: Emerging Markets Earnings Roundup (Part 1 of 2)
This article was originally published in PharmAsia News
Executive Summary
Restructuring and diversification was the theme of third quarter earnings calls, as both American and European Big Pharma companies continued to shift resources into emerging markets.